Try our Advanced Search for more refined results

In Re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation

  1. June 20, 2018

    Allergan Denies Delaying Restasis Generic In Bid To Stop MDL

    Allergan Inc. asked a New York federal court to throw out multidistrict litigation over its alleged effort to delay the launch of a generic version of Restasis, the company's dry-eye medication, saying there's no evidence its actions caused a generic not to be approved.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!